Related Experiment Video
Updated: Jul 11, 2026

New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
Thrombosis of the corpora cavernosa complicating lenalidomide therapy of myelofibrosis
Fuad A El Rassi1, Constantine S Tam, John Carwile
1Leukemia Department, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Abstract:
Venous thrombosis is a well-recognized complication of lenalidomide therapy in patients with multiple myeloma, but its occurrence during the treatment of other hematologic malignancies is less well described. In this report, we detail the occurrence of corpora cavernosa thrombosis in a patient receiving lenalidomide for the therapy of myelofibrosis. This case highlights the need for clinical vigilance in patients who present with unusual symptoms during investigational therapy, and indicates that the occurrence of venous thrombosis complicating therapy with lenalidomide or related compounds is not isolated to patients with multiple myeloma.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Hemodialysis II: Procedure and Complications
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies